Latest liver transplant Stories
Liver transplantation for hepatocellular carcinoma (HCC) is feasible for HIV-infected patients, with no differences in post-transplant survival or HCC recurrence rates compared with liver transplantation for HCC in HIV-uninfected patients. The study, published in The Oncologist, was led by Dr. Fabrizio Di Benedetto, MD, PhD, Associate Professor of Surgery, University of Modena and Reggio Emilia, Modena, Italy, and represents the largest multicenter study of liver transplant for HCC in...
Journal of American College of Surgeons study reports that, despite the risks and the costs, liver transplant may also serve as a model for gene therapy through solid organ transplantation for some patients Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases. Among the main considerations are the anxiety of waiting for a donor organ,...
EAST HANOVER, N.J., Feb. 15, 2013 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress(®) (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant. Zortress is the first mammalian target of rapamycin (mTOR) inhibitor approved for use following liver transplantation. It is also the first immunosuppressant approved by the FDA in over a decade for use following liver...
Woman thankful for a new life three years after liver transplant CHICAGO, Feb. 14, 2013 /PRNewswire-USNewswire/ -- Seven years ago, 62-year-old Margot Hamel-Christensen thought she was living a life right out of a best-selling novel. After searching numerous reunion websites, she came across her high school sweetheart's name and number. Margot sent him a note, and not long after, he responded. Margot and Ray met once again and picked up right where they left off in high school....
The lives of 39 children were saved with liver transplants by Texas Children's in 2012 HOUSTON, Jan. 31, 2013 /PRNewswire-USNewswire/ -- Texas Children's Hospital in Houston announced that in 2012 the hospital saved the lives of 39 children through liver transplantation, making it the most active pediatric liver transplant center in the nation and one of the most active in the world. To learn more about liver transplantation at Texas Children's Hospital please visit...
KANSAS CITY, Kan., Jan. 10, 2013 /PRNewswire/ -- In the Midwest Transplant Network service area, no other hospital has transplanted more organs than The University of Kansas Hospital. Two recent patients help the hospital reach a liver transplant milestone. Brenda Higgins of Kansas City was the hospital's milestone 1,000(th) liver transplant patient, followed shortly thereafter by Deborah Ellerbusch, Ph.D., a psychologist who works in Newton, Kan. "I'm overwhelmed and overjoyed at...
Tobacco in cigarettes may lower immune system response in transplant recipients Transplant recipients who smoke or have smoked increase their risk of viral hepatitis reinfection following liver transplantation according to new research available in the July issue of Liver Transplantation, a journal published by Wiley on behalf of American Association for the Study of Liver Diseases. Findings suggest that tobacco in cigarettes may adversely affect immune system response in patients...
Scientific statement from American Heart Association addresses varied cardiac evaluation and management of transplant patients As thousands of Americans await a life-saving kidney or liver transplant, medical teams are paying close attention to another organ: their hearts. This month the American Heart Association attempts to bring harmony to the varied cardiac evaluation policies created at U.S. hospitals that assess a patient's overall health before transplant surgery....
In the news release, Veloxis Pharmaceuticals to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro(TM) in Stable African-American Kidney Transplant Patients at American Transplant Congress (ATC), issued 31-May-2012 by Veloxis Pharmaceuticals A/S over PR Newswire, we are advised by the company that the end of the second paragraph should read "second quarter of 2013" rather than "second quarter of 2012" as originally issued inadvertently. The complete, corrected release...
HORSHOLM, Denmark, May 31, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that a subgroup analysis of African-American stable kidney transplant patients enrolled in Study 3001, a Phase 3 non-inferiority study, suggests that these patients may be safely converted from twice-daily Prograf(®) to once-daily LCP-Tacro. In addition, there was a trend toward fewer biopsy-proven acute rejections (BPARs) with LCP-Tacro compared to Prograf. The analysis will...
